ERYTECH PHARMA (0QSS) Share Price & Analysis

Erytech Pharma SA is a clinical-stage biopharmaceutical company. It is engaged in conducting activities in research and development in the fields of treatment for acute leukemia and other orphan diseases. The approach by the firm consists of acting on the tumor's environment and starving it so that the cancerous cells no longer have access to the growth factors that are necessary to live and proliferate. Most of the activities of the group are located in France. The company ERYCAPS proprietary platform to encapsulate active drug substances inside red blood cells using reversible hypotonic and hypertonic osmotic stress. The company's geographical segments are France and the United States, out of which the United States contributes to the majority of the revenue.